References

[1] Cunha, G. R, Hayward, S. W, & Wang, Y. Z. Role of stroma in carcinogenesis of the prostate. Differentiation (2002). , 70, 473-85.

[2] Bosman, F. T, De Bruine, A, Flohil, C, & Van Der Wurff, A. ten Kate J, Dinjens WW. Epithelial-stromal interactions in colon cancer. International Journal of Developmental Biology. (1993). , 37(1), 203-211.

[3] Seljelid, R, Jozefowski, S, & Sveinbjornsson, B. Tumor stroma. Anticancer Research. (1999). A):, 4809-22.

[4] Decosse, J. J, Gossens, C. L, Kuzma, J. F, & Unsworth, B. R. Breast cancer: induction of differentiation by embryonic tissue. Science. (1973). , 181(4104), 1057-8.

[5] Decosse, J. J, Gossens, C, Kuzma, J. F, & Unsworth, B. R. Embryonic inductive tissues that cause histologic differentiation of murine mammary carcinoma in vitro. Journal of National Cancer Institute. (1975). , 54(4), 913-22.

[6] Cooper, M, & Pinkus, H. Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth. Cancer Research. (1977). , 37, 2544-52.

[7] Arnold, J. T, & Isaacs, J. T. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. Endocrine Related Cancer. (2002). Mar;, 9(1), 61-73.

[8] Hayashi, N, Sugimura, Y, Kawamura, J, Donjacour, A. A, & Cunha, G. R. Morphological and functional heterogeneity in the rat prostatic gland. Biology of Reproduction. (1991). Aug;, 45(2), 308-21.

[9] Thompson, T. C, Timme, T. L, Kadmon, D, Park, S. H, Egawa, S, & Yoshida, K. Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate. Molecular Carcinogenesis. (1993). , 7(3), 165-79.

[10] Gabbiani, G, Hirschel, B. J, Ryan, G. B, Statkov, P. R, & Majno, G. Granulation tissue as a contractile organ. A study of structure and function. Journal of Experimental Medicine. (1972). , 135(4), 719-34.

[11] Tuxhorn, J. A, Ayala, G. E, & Rowley, D. R. Reactive stroma in prostate cancer progression. Journal of Urology. (2001). , 166, 2472-83.

[12] Sakko, A. J, Ricciardelli, C, Mayne, K, & Tilley, W. D. LeBaron RG, Horsfall DJ. Versi-can accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. Cancer Research. (2001). , 61(3), 926-930.

[13] Arnold, J. T, Kaufman, D. G, Seppala, M, & Lessey, B. A. Endometrial stromal cells regulate epithelial cell growth in vitro: a new co-culture model. Human Reproduction. (2001). , 16(5), 836-45.

[14] Macintosh, C. A, Stower, M, Reid, N, & Maitland, N. J. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Research. (1998). , 58(1), 23-28.

[15] Dakhova, O, Ozen, M, Creighton, C. J, Li, R, Ayala, G, Rowley, D, & Ittmann, M. Global gene expression analysis of reactive stroma in prostate cancer. Clinical Cancer Research. (2009). , 15(12), 3979-89.

[16] Olumi, A. F, Grossfeld, G. D, Hayward, S. W, Carroll, P. R, Tlsty, T. D, & Cunha, G. R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Research. (1999). , 59(19), 5002-11.

[17] König, J. J, Romijn, J. C, & Schröder, F. H. Prostatic epithelium inhibiting factor (PEIF): organ specificity and production by prostatic fibroblasts. Urological Research. (1987). , 15(3), 145-149.

[18] Kooistra, A, Romijn, J. C, & Schröder, F. H. Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study. Urological Research. (1997). Supplement 2): S, 97-105.

[19] Li, R, Wheeler, T, Dai, H, Frolov, A, Thompson, T, & Ayala, G. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. American Journal of Surgical Pathology. (2004). , 28(7), 928-34.

[20] Olapade-olaopa, E. O. MacKay EH, Taub NA, Sandhu DP, Terry TR, Habib FK. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma. Clinical Cancer Research. (1999). , 5(3), 569-76.

[21] Li, Y, Li, C. X, Ye, H, Chen, F, Melamed, J, Peng, Y, Liu, J, Wang, Z, Tsou, H. C, Wei, J, Walden, P, Garabedian, M. J, & Lee, P. Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion. Journal of Cellular and Molecular Medicine. (2008). B): , 2790-2798.

[22] Wikström, P, Marusic, J, Stattin, P, & Bergh, A. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients. Prostate. (2009). Jun 1;, 69(8), 799-809.

[23] Gao, J, Arnold, J. T, & Isaacs, J. T. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. Cancer Research. (2001). , 61(13), 5038-44.

[24] Morris, M. J, Huang, D, Kelly, W. K, Slovin, S. F, Stephenson, R. D, Eicher, C, Dela-cruz, A, Curley, T, Schwartz, L. H, & Scher, H. I. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer. European Urology. (2009). , 56(2), 237-44.

[25] Grant BuchananFreemasons Foundation Centre for Men's Health, The Bazil Hetzel Institute for Translational Health Research, University of Adelaide, SA, Australia.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment